Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanoch Miodownik

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Psychopharmacology|March 23, 2002
Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorderJoseph Zohar, Daniela Amital, Chanoch Miodownik, et al.
The Journal of Clinical Psychiatry|December 7, 2007
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover studyVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Clinical Neuropharmacology|February 28, 2008
Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trialVladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al.
Clinical Neuropharmacology|May 16, 2013
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical studyJoseph Bergman, Chanoch Miodownik, Yuly Bersudsky, et al.
Clinical Neuropharmacology|May 28, 2011
Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patientsChanoch Miodownik, Rachel Maayan, Yael Ratner, et al.
The Journal of Clinical Psychiatry|January 18, 2014
The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trialVladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al.
Journal of Clinical Psychopharmacology|March 31, 2016
Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With ClozapineAnatoly Kreinin, Chanoch Miodownik, Vitaly Mirkin, et al.
Clinical Neuropharmacology|May 3, 2019
Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyChanoch Miodownik, Vladimir Lerner, Natalie Kudkaeva, et al.
Indian Journal of Psychiatry|February 29, 2024
Risk factors for coercion length at psychiatric hospitals in Israel: Relationship with staffChanoch Miodownik, Michael D Friger, Alexander Teitelbaum, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Psychopharmacology|March 23, 2002
Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorderJoseph Zohar, Daniela Amital, Chanoch Miodownik, et al.
The Journal of Clinical Psychiatry|December 7, 2007
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover studyVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Clinical Neuropharmacology|February 28, 2008
Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trialVladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al.
Clinical Neuropharmacology|May 16, 2013
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical studyJoseph Bergman, Chanoch Miodownik, Yuly Bersudsky, et al.
Clinical Neuropharmacology|May 28, 2011
Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patientsChanoch Miodownik, Rachel Maayan, Yael Ratner, et al.
The Journal of Clinical Psychiatry|January 18, 2014
The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trialVladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al.
Journal of Clinical Psychopharmacology|March 31, 2016
Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With ClozapineAnatoly Kreinin, Chanoch Miodownik, Vitaly Mirkin, et al.
Clinical Neuropharmacology|May 3, 2019
Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyChanoch Miodownik, Vladimir Lerner, Natalie Kudkaeva, et al.
Indian Journal of Psychiatry|February 29, 2024
Risk factors for coercion length at psychiatric hospitals in Israel: Relationship with staffChanoch Miodownik, Michael D Friger, Alexander Teitelbaum, et al.
Pageof 4